---
title: continuous glucose monitoring
videoId: eHJXh5zvOHU
---

From: [[foundmyfitness]] <br/> 

Continuous Glucose Monitors (CGMs) are devices that allow individuals to track their blood glucose levels in real-time, providing insights into how different foods and lifestyle choices impact their [[metabolic_therapies_in_disease_management | metabolic health]] <a class="yt-timestamp" data-t="00:00:47">[00:00:47]</a>. Originally considered medical devices prescribed under physician care <a class="yt-timestamp" data-t="00:07:04">[00:07:04]</a>, companies like NutriSense, January.AI, and Levels have made them widely accessible to the general public through physician networks <a class="yt-timestamp" data-t="00:07:13">[00:07:13]</a>. Well-known CGM brands include Dexcom and Freestyle Libre <a class="yt-timestamp" data-t="00:07:24">[00:07:24]</a>.

## Why Measure Glucose?

Monitoring glucose levels is crucial for understanding and managing health, particularly in the context of [[metabolic_therapies_in_disease_management | metabolic health]] disorders like type 2 diabetes and pre-diabetes <a class="yt-timestamp" data-t="00:03:14">[00:03:14]</a>.

### The Problem of Undiagnosed Pre-diabetes

A significant challenge in public health is that about 9 out of 10 people with pre-diabetes are unaware of their condition <a class="yt-timestamp" data-t="00:05:30">[00:05:30]</a>. This means their glucose levels are beginning to go "out of control" <a class="yt-timestamp" data-t="00:05:36">[00:05:36]</a>. While 9% of the U.S. population is diabetic, 33% are pre-diabetic, with most eventually progressing to full-blown diabetes <a class="yt-timestamp" data-t="00:05:46">[00:05:46]</a>. Early detection through CGM is considered critical to enable individuals to manage their glucose levels well in advance <a class="yt-timestamp" data-t="00:06:00">[00:06:00]</a>.

> "9 out of 10 people who have pre-diabetes, so not yet diabetes, actually have no idea." <a class="yt-timestamp" data-t="00:05:30">[00:05:30]</a>

Normal glucose levels are typically 90 or below, with levels over 120 generally classifying someone as type 2 diabetic; the range in between is considered pre-diabetes <a class="yt-timestamp" data-t="00:07:37">[00:07:37]</a>. However, these are arbitrary numbers, as glucose levels can fluctuate significantly based on diet and other factors <a class="yt-timestamp" data-t="00:07:45">[00:07:45]</a>.

### Dr. Snyder's Personal Experience

Dr. Michael Snyder, Chair of the Department of Genetics at Stanford, discovered his own type 2 diabetes predisposition through genome sequencing <a class="yt-timestamp" data-t="00:02:59">[00:02:59]</a>. Despite not being overweight, exercising regularly, and lacking a family history of type 2 diabetes <a class="yt-timestamp" data-t="00:03:04">[00:03:04]</a>, his genome indicated a high risk <a class="yt-timestamp" data-t="00:03:38">[00:03:38]</a>. Nine months into a personal health study, his sugar levels began to rise significantly <a class="yt-timestamp" data-t="00:03:26">[00:03:26]</a>. He was diagnosed as type 2 diabetic, a condition believed to be triggered by a nasty viral infection three weeks prior, which has relevance to the current COVID-19 pandemic <a class="yt-timestamp" data-t="00:04:38">[00:04:38]</a>.

His unique case revealed that while his cells were insulin sensitive and he produced insulin, he didn't release it effectively from his pancreas <a class="yt-timestamp" data-t="00:12:17">[00:12:17]</a>. This highlights that diabetes may encompass "50 different diseases" rather than just type 1 or type 2, emphasizing the need for personalized therapies <a class="yt-timestamp" data-t="00:10:27">[00:10:27]</a>. Dr. Snyder, for example, did not respond to metformin but found success with repaglinide, a drug that promotes insulin release <a class="yt-timestamp" data-t="00:12:28">[00:12:28]</a>.

## Personalization of Diet and [[exercise_snacks_and_their_role_in_glucose_regulation_and_metabolic_health | Exercise]]

CGMs are powerful tools for understanding individual responses to food <a class="yt-timestamp" data-t="00:08:29">[00:08:29]</a>. Different foods can cause significant glucose spikes in different people due to variations in their microbiome <a class="yt-timestamp" data-t="00:08:25">[00:08:25]</a>.

*   **Food Awareness:** Dr. Snyder learned that pulled pork, due to hidden sugar in the sauce, could send his glucose levels over 350 <a class="yt-timestamp" data-t="00:08:12">[00:08:12]</a>. Another example cited was balsamic dressing on salmon and salad, which contained sugar and caused a spike <a class="yt-timestamp" data-t="00:14:56">[00:14:56]</a>. White rice <a class="yt-timestamp" data-t="00:15:34">[00:15:34]</a> and cornflakes with milk <a class="yt-timestamp" data-t="00:15:41">[00:15:41]</a> are commonly observed to cause spikes.
*   **Behavior Modification:** CGMs allow individuals to see what foods cause spikes and then personalize their eating habits, avoiding foods that negatively impact their glucose regulation <a class="yt-timestamp" data-t="00:10:54">[00:10:54]</a>. Companies like January AI use this data to provide food recommendations <a class="yt-timestamp" data-t="00:11:05">[00:11:05]</a>.
*   **[[exercise_snacks_and_their_role_in_glucose_regulation_and_metabolic_health | Exercise]] Impact:** CGMs clearly demonstrate the immediate benefits of [[exercise_snacks_and_their_role_in_glucose_regulation_and_metabolic_health | exercise]] on glucose levels <a class="yt-timestamp" data-t="00:15:23">[00:15:23]</a>. For instance, a brisk 15-minute walk after eating white rice can significantly suppress glucose spikes <a class="yt-timestamp" data-t="00:15:53">[00:15:53]</a>.
*   **Other Factors:** Lack of sleep has also been identified as a factor that can impact fasting blood glucose <a class="yt-timestamp" data-t="00:16:44">[00:16:44]</a>.

### CGM for the General Population

Dr. Snyder advocates for everyone to wear a CGM, even those without pre-diabetes or diabetes <a class="yt-timestamp" data-t="00:09:45">[00:09:45]</a>. Many seemingly "normal" people might experience glucose spikes without realizing it <a class="yt-timestamp" data-t="00:10:06">[00:10:06]</a>. CGMs are effective at identifying glucose dysregulation that might not be apparent through standard measures like final glucose levels or hemoglobin A1C tests <a class="yt-timestamp" data-t="00:10:11">[00:10:11]</a>.

## Integration with Big Data for Precision Medicine

The use of CGMs is part of a larger movement towards precision medicine, which involves collecting vast amounts of personal health data to understand health status and detect disease early <a class="yt-timestamp" data-t="00:17:17">[00:17:17]</a>.

### Comprehensive Profiling

Dr. Snyder's Innovation Lab at Stanford conducts deep molecular measurements, including sequencing DNA for genetic risk factors <a class="yt-timestamp" data-t="00:02:06">[00:02:06]</a>, analyzing tens of thousands of molecules from blood and urine <a class="yt-timestamp" data-t="00:02:18">[00:02:18]</a>, studying the microbiome from stool samples <a class="yt-timestamp" data-t="00:02:24">[00:02:24]</a>, and utilizing data from wearables like smartwatches and rings <a class="yt-timestamp" data-t="00:02:29">[00:02:29]</a>.

> "More information is always better than less information." <a class="yt-timestamp" data-t="00:01:57">[00:01:57]</a>

### Early Disease Detection

This "big data" approach aims to shift healthcare from a treatment-focused system to one emphasizing prevention alongside treatment <a class="yt-timestamp" data-t="00:00:27">[00:00:27]</a>. By establishing individual baselines and monitoring shifts over time, conditions can be detected before symptoms appear <a class="yt-timestamp" data-t="00:09:13">[00:09:13]</a>. In a study of 109 people, nearly half learned something important about their health within three years, including early lymphoma, pre-cancers, serious heart issues, and undiagnosed diabetes <a class="yt-timestamp" data-t="00:20:13">[00:20:13]</a>. Detection often comes from a combination of different [[biomarkers_in_health_monitoring | biomarker]] data, such as genome sequences, protein markers, and imaging <a class="yt-timestamp" data-t="00:21:02">[00:21:02]</a>.

### Ageotypes

Longitudinal data collection allows researchers to observe how individuals age differently, a concept termed "ageotypes" <a class="yt-timestamp" data-t="00:48:26">[00:48:26]</a>. These can include metabolic, kidney, liver, or immune aging <a class="yt-timestamp" data-t="00:49:19">[00:49:19]</a>. Understanding one's ageotype provides actionable information for health management, such as increasing water intake for kidney agers or reducing alcohol for liver agers <a class="yt-timestamp" data-t="00:50:55">[00:50:55]</a>. This approach allows for personalized interventions and the ability to test if they can reverse or slow down aging processes <a class="yt-timestamp" data-t="00:51:57">[00:51:57]</a>.

## Conclusion

Continuous glucose monitoring, as part of a broader "big data" approach to health, holds immense potential for transforming healthcare by empowering individuals with personalized insights and enabling early detection and prevention of disease <a class="yt-timestamp" data-t="00:22:04">[00:22:04]</a>.